Abstract 4364473: Impact of side branch calcification on bifurcation percutaneous coronary intervention: Analysis from the PROGRESS-BIFURCATION registry
Abstract
Background: The impact of side branch (SB) calcification on the outcomes of bifurcation percutaneous coronary intervention (PCI) remains understudied. Methods: We examined the impact of SB calcification assessed by coronary angiography on procedural characteristics and outcomes of 1,866 bifurcation PCIs (1,646 patients) performed at five centers between 2014-2025 from the PROGRESS-BIFURCATION registry (NCT05100992). Results: Moderate or severe SB calcification was present in 420 patients (25.5%). Patients with moderate or severe SB calcification were older and had more comorbidities including hypertension, dyslipidemia, history of heart failure, prior myocardial infarction, PCI and coronary artery bypass graft surgery. Moderate or severe SB calcification lesions were more complex with higher left main (LM), left anterior descending, left circumflex and right coronary artery stenoses, higher V-RESOLVE scores (16 vs 13, p<0.001), higher rates of ostial lesions (18.6% vs 6.0%, p<0.001), moderate or severe main vessel calcification (95% vs 19%, p<0.001) and longer side branch lesion length (10 vs 5 mm, p<0.001). In patients with vs without moderate or severe SB calcification the main vessel was more likely to be the LM (46.2% vs 17.6%, p <0.001) and two-stent techniques were more likely to be used (42.3% vs 25.0%, p<0.001) while provisional stenting use was lower (51.7% vs 70.5%, p<0.001). Technical success was similar (93.5% vs 95.1%, p=0.182) and procedural success was lower (88.3% vs 92.7%, p=0.005) in patients with moderate or severe SB calcification driven by higher major adverse cardiovascular events (MACE) (5.5% vs 2.7%, p=0.007). Moderate or severe SB calcification was associated with longer fluoroscopy (28 vs 18 min, p<0.001) and procedure times (114 vs 67 min, p<0.001), higher air kerma radiation dose (1.65 vs 1.30 Gy, p<0.001), and higher in-hospital mortality (2.1% vs 0.7%, p=0.026). During a median follow-up of 1,037 days moderate or severe SBC was independently associated with higher MACE (adjusted hazard ratio [HR]: 1.49, 95% confidence interval [CI]: 1.14, 1.95, p=0.004), driven by higher mortality (HR: 2.63, CI: 1.96, 3.53, p<0.001), target vessel revascularization (HR: 1.73, CI: 1.23, 2.42, p=0.001) and MI (HR:1.53, CI: 0.99, 2.36, p=0.036) Conclusions: Bifurcation PCI in patients with moderate or severe SB calcification was associated with higher complexity and worse in-hospital and follow-up outcomes.
Article Details
Authors (23)
Dimitrios Strepkos
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Michaella Alexandrou
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Deniz Mutlu
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Pedro Carvalho
Ernst Strüngmann Institute
Eleni Kladou
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Ozgur Ser
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Sandeep Jalli
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Oleg Krestyaninov
NMRC E.N. Meshalkin, Novosibirsk, Russian Federation
Dmitrii Khelimskii
NMRC E.N. Meshalkin, Novosibirsk, Russian Federation
Barkin Kultursay
Kartal Kosuyolu Heart Hospital, Istanbul, Turkey
Ali Karagoz
Kartal Kosuyolu Heart Hospital, Istanbul, Turkey
Ufuk Yildirim
Ondokuz Mayis University, Samsun, Turkey
korhan soylu
Ondokuz Mayis University, Samsun, Turkey
Mahmut Uluganyan
Bezmialem Vakif University, Istanbul, Turkey
Kadriye Kilickesmez
Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey
Gokhan Cetinkal
Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey
Sefa SURAL
Medicalpark Hospital, Mersin, Turkey
Olga Mastrodemos
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Bavana Rangan
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Konstantinos Voudris
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Yader Sandoval
Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital and Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation Minneapolis
M Nicholas Burke
Minneapolis Heart Institute, Mpls, Minnesota, United States
Emmanouil Brilakis
Minneapolis Heart Institute, Edina, Minnesota, United States